Psychedelic therapy: a roadmap for wider acceptance and utilization.

@article{Marks2021PsychedelicTA,
  title={Psychedelic therapy: a roadmap for wider acceptance and utilization.},
  author={Mason Marks and Ivan Glenn Cohen},
  journal={Nature medicine},
  year={2021}
}
View on PubMed
nature.com
9 Citations
Background Citations
2

9 Citations

Novel ethical and policy issues in psychiatric uses of psychedelic substances
Physical Disability and Psychedelic Therapies: An Agenda for Inclusive Research and Practice
TLDR
The need for extensive disability awareness training for those facilitating psychedelic therapies and the encouragement of psychedelic researchers and therapists to exercise cultural humility toward individuals with physical and sensory disabilities are emphasized.
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials.
RATIONALE Psychedelic research continues to garner significant public and scientific interest with a growing number of clinical studies examining a wide range of conditions and disorders. However,…
Counselors’ attitudes toward psychedelics and their use in therapy
A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders
TLDR
Methylenedioxymethamphetamine and psilocybin may show promise in highly selected populations when administered in closely supervised settings and with intensive support, and both agents were well tolerated in supervised trials.
The therapeutic potential of psychedelic-assisted therapies for symptom control in patients diagnosed with serious illness: a systematic review.
Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history
Great Expectations: Recommendations for improving the methodological rigor of psychedelic clinical trials
Rationale: Psychedelic research continues to garner significant public and scientific interest with a growing number of clinical studies examining a wide range of conditions and disorders. However,…
Acid Revival: The Psychedelic Renaissance and the Quest for Medical Legitimacy

References

SHOWING 1-8 OF 8 REFERENCES
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
This randomized clinical trial examines the efficacy of psilocybin as an adjunct to psychotherapy and other treatments for major depressive disorder.
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer
Background: A recently published randomized controlled trial compared single-dose psilocybin with single-dose niacin in conjunction with psychotherapy in participants with cancer-related psychiatric…
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
TLDR
MDMA-assisted psychotherapy was efficacious and well tolerated in a large sample of adults with PTSD and supported expansion into phase 3 trials and led to FDA granting Breakthrough Therapy designation for this promising treatment.
Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature
TLDR
Inclusion of minorities in futures studies and improved recruitment strategies are necessary to better understand the efficacy of psychedelic-assisted psychotherapy in people of color and provide all with equal opportunities for involvement in this potentially promising treatment paradigm.
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
TLDR
High-dose psilocybin produced large decreases in clinician- and self-rated measures of depressed mood and anxiety, along with increases in quality of life, life meaning, and optimism, and decreases in death anxiety.
Harm potential of magic mushroom use: a review.
Psilocybin for treating substance use disorders?
TLDR
A summary of (human) studies on the putative therapeutic effects of psilocybin is provided, and the receptor systems, brain regions and cognitive and emotional processes mediating p silocybin’s effects are discussed.